Liposomal Irinotecan Safety Reminder
Version: 1 ID: GL-C50-35 Sep 2017
Type of Content: Drug Safety, Guidelines & Advice, Clinical
Document Status: Current
The Systemic Treatment Program would like to remind healthcare providers to be vigilant against potential medication errors with liposomal irinotecan.
Intended Guideline Users
Health care professionals (MDs, nurses, pharmacists)
Full Report (PDF) (101.28 KB)